Ornithine Transcarbamylase OTC Deficiency Treatment Market Analysis and Future Trends 2024 – 2032
Ornithine Transcarbamylase (OTC) deficiency is a rare genetic disorder that affects the urea cycle, leading to a buildup of ammonia in the blood, which can cause neurological damage and other severe health complications if untreated. OTC deficiency is the most common urea cycle disorder, and it is caused by mutations in the OTC gene located on the X chromosome. This condition mainly affects...
0 Comments 0 Shares 141 Views 0 Reviews